Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Ad Division Will Increase Focus On Outcomes Claims After Reorganization

Executive Summary

FDA's reorganized Division of Drug Marketing, Advertising & Communication will be increasing its focus on promotions based on outcomes data, Division Director Tom Abrams said during the Drug Information Association's annual meeting in Chicago June 18

You may also be interested in...

FDA Ad Division Reorganization Splits Review Of Professional, DTC Materials

FDA's Division of Drug Marketing, Advertising & Communications is reorganizing its enforcement and review staff into health professional and consumer review groups

FDA Quality Of Life, Pharmacoeconomic Guidance Development On Hold

FDA development of guidances for including quality of life claims in drug labeling and promotions and for formulary-directed pharmacoeconomic information is on hold until more information is collected.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts